- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01058694
The Impact of Short Message Services (SMS) on ARV Adherence in Western Kenya (CAPS)
Adherence to ARV Treatment and Its Effects on Medium Run Socio-Economic Outcomes: Evidence From Western Kenya
The purpose of proposed research is to implement a randomized study that will allow us to understand and address a number of key barriers to patient adherence as well as study the effects of better adherence on health and socio-economic outcomes.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Several studies have shown that proper adherence to treatment regimens is essential for the effectiveness of ARV therapy (e.g Wools-Kaloustian et al. 2006). There is also evidence in that in some treatment programs in Africa, adherence rates are not always high (Gill et al. 2005). Even in settings where adherence levels are found to be high, numerous factors have been identified as being relevant, although the causal effects are unknown (Castro, 2006). As ARV treatment programs are scaled up in Africa, it is essential to understand the socio-economic determinants of adherence to ARV treatment, as well as the impact of interventions to support high levels of adherence. A secondary objective of this study is to understand the socio-economic impacts of higher adherence.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Maseno District
-
Kisumu, Maseno District, Kenya
- Chulaimbo Rural Health Center
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Patients who had been on ARV therapy at the Chulaimbo Rural Health Center for a maximum of three months and providing consent to participate in the study.
Exclusion Criteria:
- Patients who had been on ARV therapy for more than 3 months.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Faktoriel opgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Weekly SMS, brief message
Weekly SMS received on Monday at 12 noon |
Short message services were sent to randomly selected consenting subjects on ARV therapy. The frequency and content of the message is varied in a factorial design. |
|
Aktiv komparator: Control Group
Receives a phone, but no messages. |
Short message services were sent to randomly selected consenting subjects on ARV therapy. The frequency and content of the message is varied in a factorial design. |
|
Eksperimentel: Daily SMS, Brief message
Receive daily brief message at 12 noon: "This is your reminder" |
Short message services were sent to randomly selected consenting subjects on ARV therapy. The frequency and content of the message is varied in a factorial design. |
|
Eksperimentel: Daily SMS, Long Message
Receive a daily long message at 12 noon: "This is your reminder + encouragement" |
Short message services were sent to randomly selected consenting subjects on ARV therapy. The frequency and content of the message is varied in a factorial design. |
|
Eksperimentel: Weekly SMS, Long Message
Weekly message sent at 12 noon on Mondays: "This is your reminder + encouragement" |
Short message services were sent to randomly selected consenting subjects on ARV therapy. The frequency and content of the message is varied in a factorial design. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
MEMS Adherence
Tidsramme: 12 months follow up
|
12 months follow up
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Frequency/incidence of ARV treatment interruptions
Tidsramme: 12 months follow up
|
12 months follow up
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: John Sidle, MD, Indiana University
- Ledende efterforsker: Duncan Ngare, Phd, Moi University
- Ledende efterforsker: Harsha Thirumurthy, Phd, University of North Carolina
- Ledende efterforsker: Markus Goldstein, Phd, World Bank
- Ledende efterforsker: Joshua Graff-Zivin, Phd, University of California, San Diego
- Ledende efterforsker: Cristian Pop-Eleches, Phd, Columbia University
- Ledende efterforsker: David Bangsberg, MD, Harvard Medical School (HMS and HSDM)
- Ledende efterforsker: Damien de Walque, Phd, World Bank
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Anslået)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Blodbårne infektioner
- Urogenitale sygdomme
- Genitale sygdomme
- Sygdomme i immunsystemet
- Infektioner
- RNA-virusinfektioner
- Virussygdomme
- Overførbare sygdomme
- Seksuelt overførte sygdomme, virale
- Seksuelt overførte sygdomme
- Lentivirus infektioner
- Retroviridae infektioner
- Immunologiske mangelsyndromer
- Langsomme virussygdomme
- Opførsel
- Behandlingsoverholdelse og compliance
- Sundhedsadfærd
- Patient Compliance
- Patientaccept af sundhedspleje
- HIV-infektioner
- Erhvervet immundefektsyndrom
- Medicinadhærens
Andre undersøgelses-id-numre
- 2008-005
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .